Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment. - Wikidata - wikimedia - TriplyDB

Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment.

Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment.

http://www.wikidata.org/entity/Q38955887

about

Detection of Serum Antibodies to Hepatitis E Virus Based on HEV Genotype 3 ORF2 Capsid Protein Expressed in Nicotiana benthamiana.Non-canonical Translation in Plant RNA Viruses.Antibodies from plants for bionanomaterials.In Planta Synthesis of Designer-Length Tobacco Mosaic Virus-Based Nano-Rods That Can Be Used to Fabricate Nano-Wires.Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine.Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine.A transatlantic perspective on 20 emerging issues in biological engineering.Progress in biopharmaceutical development.Introduction to the thematic minireview series: green biological chemistry.Three unrelated protease inhibitors enhance accumulation of pharmaceutical recombinant proteins in N. benthamiana.Recombinant protein susceptibility to proteolysis in the plant cell secretory pathway is pH-dependent.Plant-made Salmonella bacteriocins salmocins for control of Salmonella pathovars.Advanced Plant-Based Glycan Engineering.New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.

P2860

Q33614391-82208CBA-AD28-42CE-B0C8-A5298DC16628 Q38692480-C9E66D87-F2C0-4658-9A56-940ED42FD931 Q38739385-06FB882B-4B01-4963-8A16-FFAF4EB217AB Q40054695-622EF535-C0E5-4BEF-872D-7FF1D23CAF3D Q40082018-13F788FB-3779-4AC5-A168-D6E9D1BBFA6D Q40097092-4BCAD37C-6FA6-45F1-ADE8-A5C0BD636D59 Q40145707-B7ADA1CB-A6B3-4614-86AC-270395986FD6 Q44877018-699712F3-D44F-4807-8E1C-BC5388D0500A Q48253463-D439850B-1BC3-4204-828C-F4E0D51F0B14 Q50146915-5BF6A19B-5C56-4F9B-A924-BA6652D1BC1A Q52671766-452ACCCE-0DE5-42B2-8EDD-3C7100CC2E44 Q52721608-95833F4F-BC1E-45F4-B6A0-640AF102C08A Q54988047-AFAAC6C1-3827-4972-BEF1-289B30ADD17F Q55401613-642E1728-497C-436E-832D-81627743CA6D Q55668744-F352CDF9-31EC-425D-93A5-323D94102810

P2860

Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment.

http://www.wikidata.org/entity/Q38955887

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Plant-produced biopharmaceutic ...... s driving clinical deployment.

@en

type

label

Plant-produced biopharmaceutic ...... s driving clinical deployment.

@en

prefLabel

Plant-produced biopharmaceutic ...... s driving clinical deployment.

@en

P1433

Q38955887-FF8060AB-1E32-470A-84EC-C91E274FE5E1

P1476

Q38955887-04123506-6598-4AD9-B87E-C9A8F00A8D48

P2093

Q38955887-5CFBAB8B-2E50-4136-A23D-3229B421F9D7

Q38955887-A20BB10C-1F1A-4275-9B98-860D7A590913

P2860

Q38955887-00817708-4031-4CA7-BB8A-4034014AEAAE

Q38955887-14B15741-E7EA-4CCF-8561-F606E0D2E3B5

Q38955887-255B4B80-9338-44CD-A006-824E371FC3E3

Q38955887-2FD15A61-5B65-4990-9587-54D154B96166

Q38955887-337001D6-5821-4177-ACD5-9D805636D38D

Q38955887-3C595BFC-D2CB-4637-B56F-BB5C739947CE

Q38955887-4C593DAC-0E42-4033-9F2F-2F764D1285F3

Q38955887-4EB823DD-BF6A-41B1-ADBA-9E0A584F2993

Q38955887-521600D5-495A-4410-AB54-2C94E09DAA22

Q38955887-616DD813-AF90-4C24-8478-19A2D04EF4B6

P304

Q38955887-C8A923AC-D23C-41D2-BD94-2E53A248A75C

P31

Q38955887-BBA9FA9A-0130-4D9C-B5B2-3ECD961C9360

P356

Q38955887-008ECF05-FC5D-4893-821E-3DC01BE8EECE

P407

Q38955887-854686A5-4BB8-45F3-B92A-ED662FD289F5

P433

Q38955887-4A1741E4-BFF4-421B-A0F6-272CFDDE4E97

P478

Q38955887-B28A0671-4A47-4E63-9F9F-55891D2F5F4C

P577

Q38955887-3CB45258-5225-4306-AE3E-0F241DD432A2

P698

Q38955887-00B2E0B8-8B53-409A-BF63-F95A821344E8

P356

SCIENCE.AAF6638

P1433

P1476

Plant-produced biopharmaceutic ...... s driving clinical deployment.

@en

P2093

George P Lomonossoff

http://www.w3.org/2001/XMLSchema#string

Marc-André D'Aoust

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications

Molecular pharming - VLPs made in plants

Large-scale production of pharmaceutical proteins in plant cell culture-the Protalix experience

Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system

When plant virology met Agrobacterium: the rise of the deconstructed clones

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.

Expression and glycoengineering of functionally active heteromultimeric IgM in plants.

Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease.

P304

1237-1240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAF6638

http://www.w3.org/2001/XMLSchema#string

P407

P433

6305

http://www.w3.org/2001/XMLSchema#string

P478

353

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27634524

http://www.w3.org/2001/XMLSchema#string